Method For Labeling A Prostate-Specific Membrane Antigen Ligand With A Radioactive Isotope - EP3763394

The patent EP3763394 was granted to Isotopia Molecular Imaging on Nov 8, 2023. The application was originally filed on Mar 2, 2016 under application number EP20193861A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3763394

ISOTOPIA MOLECULAR IMAGING
Application Number
EP20193861A
Filing Date
Mar 2, 2016
Status
Granted And Under Opposition
Oct 6, 2023
Grant Date
Nov 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEAug 1, 2024CARPMAELS & RANSFORDADMISSIBLE
TELIX INNOVATIONSAug 1, 2024DE CLERCQ & PARTNERSADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONUS2010324008
OPPOSITIONUS2013310537
OPPOSITIONUS2014140925
OPPOSITIONWO03059397
OPPOSITIONWO2005009393
OPPOSITIONWO2009002529
OPPOSITIONWO2013024013

Non-Patent Literature (NPL) Citations (38) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- EDER M. et al., "Novel preclinical and radiopharmaceutical aspects of [68Ga]Ga-PSMA-HBED-CC: A new PET tracer for imaging of prostate cancer", Pharmaceuticals, (20140000), vol. 7, doi:10.3390/ph7070779, pages 779 - 796, XP055280737
EXAMINATION- FORRER F ET AL, "Treatment with<177>Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with<90>Y-DOTATOC", JOURNAL OF NUCLEAR MEDICINE 2005 US, (2005), vol. 46, no. 8, ISSN 0161-5505, pages 1310 - 1316, XP093201854-
EXAMINATION- WATERHOUSE N N ET AL, Otto: a 4.04 GBq (109 mCi) <68>Ge/<68>Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [<68>Ga]Ga-PSMA-11, EJNMMI RADIOPHARMACY AND CHEMISTRY 20201201 SPRINGER SCIENCE AND BUSINESS MEDIA DEUTSCHLAND GMBH CHE, VOL. 5, NR. 1, (20201201), ISSN 2365-421X-
EXAMINATION- MCCARTHY M ET AL, "Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 20170801 SPRINGER BERLIN HEIDELBERG DEU, (20170801), vol. 44, no. 9, doi:10.1007/s00259-017-3699-z, ISSN 1619-7070, pages 1455 - 1462, XP036274112
OPPOSITION- Anonymous, "Chemistry Report GID: 013769 Reference: 8644-2023-0101 68Ga-PSMA-11", Chemistry Report, Invicro, (20240131), pages 1 - 7, Chemistry Report, URL: https://invicro.com/, XP093202856-
OPPOSITION- Anonymous, "Good Radiopharmaceutical Practice - Dimensions of GRP ® Modules ", GRP-Brochure II, SCINTOMICS GmbH, (20130531), pages 1 - 20, GRP-Brochure II, URL: https://web.archive.org/web/20130531012732if_/http://www.scintomics.com:80/cms/upload/pdf/gpr-series/SCINTOMICS_GRP_Brochure_II_V1.0_lR.pdf, XP093201870-
OPPOSITION- Anonymous, "Good Radiopharmaceutical Practice - PRI & PRRT on GRP Systems", GRP-Brochure III, SCINTOMICS GmbH, (20130531), pages 1 - 20, GRP-Brochure III, URL: https://web.archive.org/web/20130531012558if_/http://www.scintomics.com:80/cms/upload/pdf/gpr-series/SCINTOMICS_GRP_Brochure_III_V1.0_lR.pdf, XP093201871-
OPPOSITION- Anonymous, "Radiopharmaceutical products", Quality Assurance of Pharmaceuticals : Good Manufacturing Practices and Inspection - A Compendium of Guidelines and Related Materials, Geneva, CH, World Health Organization, (20070101), vol. 2, pages 276 - 284, ISBN 978-92-4-154708-6, XP093202848-
OPPOSITION- Anonymous, "Reducing complexity - focusing on the essential", GMP production with GRP (Good Radiopharmaceutical Practice) modules, SCINTOMICS GmbH, (20140520), pages 1 - 2, GMP production with GRP (Good Radiopharmaceutical Practice) modules, URL: https://web.archive.org/web/20140520142309/http://www.scintomics.com:80/en/production/grp-modules/index.html, XP093201866-
OPPOSITION- Anonymous, "SCINTOMICS GRP® - Good Radiopharmaceutical Practice - Reducing complexity - focusing on the essential", GRP-Brochure I, SCINTOMICS GmbH, (20130531), pages 1 - 16, GRP-Brochure I, URL: https://web.archive.org/web/20130531013022if_/http://www.scintomics.com:80/cms/upload/pdf/gpr-series/SCINTOMICS_GRP_Brochure_I_V1.1.pdf, XP093201868-
OPPOSITION- Deutsch Edward, "Clinical PET: its time has come", The Journal of Nuclear Medicine, Society of Nuclear Medicine, US, US , (19930701), vol. 34, no. 7, ISSN 0161-5505, pages 1132 - 1133, XP093201863-
OPPOSITION- Forrer Flavio, Uusija Helena, Storch Daniel, Maecke Helmut R, Mueller-Brand Jan, "Treatment with 177 Lu-DOTATOC of Patients with Relapse of Neuroendocrine Tumors After Treatment with 90 Y-DOTATOC", The Journal of Nuclear Medicine, Society of Nuclear Medicine, US, US , (20050801), vol. 46, no. 8, ISSN 0161-5505, pages 1310 - 1316, XP093201854-
OPPOSITION- Nawaz Saima, "A New Gallium-68 Labelled Imaging Agent for Prostate Cancer ", Dissertation, King's College London, (20130901), pages 1 - 187, XP093201874-
OPPOSITION- Noeen Malik, Boris Zlatopolskiy, Hans-Juergen Machulla, Sven N Reske, Christoph Solbach, "One pot radiofluorination of a new potential PSMA ligand [Al18F]NOTA-DUPA-Pep", Journal of Labelled Compounds and Radiopharmaceuticals, Wiley., (20120709), vol. 55, no. 9, doi:10.1002/jlcr.2944, ISSN 03624803, pages 320 - 325, XP055214738
OPPOSITION- Chiotellis E., "Chapter 7: Lyophilization Technique for Preparing Radiopharmaceutical Kits", Technetium-99m pharmaceuticals : preparation and quality control in nuclear medicine, Springer, (20161107), pages 99 - 102, doi:10.1007/978-3-540-33990-8_7, ISBN 978-3-540-33989-2, XP093202842
OPPOSITION- Afshar-Oromieh A., Malcher A., Eder M., Eisenhut M., Linhart H. G., Hadaschik B. A., Holland-Letz T., Giesel F. L., Kratochwil C., Haufe S., Haberkorn U., Zechmann C. M., "PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions", European Journal of Nuclear Medicine and Molecular Imaging, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20130401), vol. 40, no. 4, doi:10.1007/s00259-012-2298-2, ISSN 1619-7070, pages 486 - 495, XP093097827
OPPOSITION- Afshar-Oromieh A.; Haberkorn U.; Schlemmer H. P.; Fenchel M.; Eder M.; Eisenhut M.; Hadaschik B. A.; Kopp-Schneider A.; Röthke M. , "Comparison of PET/CT and PET/MRI hybrid systems using a68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience", European Journal of Nuclear Medicine and Molecular Imaging, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20131219), vol. 41, no. 5, doi:10.1007/s00259-013-2660-z, ISSN 1619-7070, pages 887 - 897, XP035342031
OPPOSITION- Kratochwil Clemens; Giesel Frederik L.; Eder Matthias; Afshar-Oromieh Ali; Benešová Martina; Mier Walter; Kopka Klaus; Haberkorn , "[177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer", European Journal of Nuclear Medicine and Molecular Imaging, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20150109), vol. 42, no. 6, doi:10.1007/s00259-014-2978-1, ISSN 1619-7070, pages 987 - 988, XP035444727
OPPOSITION- Archana Mukherjee, Usha Pandey, Rubel Chakravarty, Haladhar Dev Sarma, Ashutosh Dash, "Development of Single Vial Kits for Preparation of 68Ga-Labelled Peptides for PET Imaging of Neuroendocrine Tumours", Molecular Imaging & Biology, Elsevier, Boston, Boston , (20140801), vol. 16, no. 4, doi:10.1007/s11307-014-0719-2, ISSN 1536-1632, pages 550 - 557, XP055289358
OPPOSITION- Martin René, Jüttler Steffen, Müller Marco, Wester Hans-Jürgen, "Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2", Nuclear Medicine and Biology, ELSEVIER, NY., US, US , (20140101), vol. 41, no. 1, doi:10.1016/j.nucmedbio.2013.09.002, ISSN 0969-8051, pages 84 - 89, XP093201857
OPPOSITION- I. Velikyan, Beyer G. J., Långström B., "Microwave-Supported Preparation of 68 Ga Bioconjugates with High Specific Radioactivity", Bioconjugate Chemistry - Author Manuscript, American Chemical Society, US, US , (20040501), vol. 15, no. 3, doi:10.1021/bc030078f, ISSN 1043-1802, pages 554 - 560, XP055338751
OPPOSITION- Matthias Eder, Martin Schäfer, Ulrike Bauder-Wüst, William-Edmund Hull, Carmen Wängler, Walter Mier, Uwe Haberkorn, Michael Eisenhut, "68 Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging", Bioconjugate Chemistry, American Chemical Society, (20120418), vol. 23, no. 4, doi:10.1021/bc200279b, ISSN 10431802, pages 688 - 697, XP055043532
OPPOSITION- Sumith A. Kularatne, Zhigang Zhou, Jun Yang, Carol B. Post, Philip S. Low, "Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99m Tc-Radioimaging Agents", Molecular Pharmaceutics, American Chemical Society, US, US , (20090601), vol. 6, no. 3, doi:10.1021/mp9000712, ISSN 1543-8384, pages 790 - 800, XP055400629
OPPOSITION- Amor-Coarasa Alejandro, Milera Andrew, Carvajal Denny, Gulec Seza, Mcgoron Anthony J., "Lyophilized Kit for the Preparation of the PET Perfusion Agent [ 68 Ga]-MAA", International Journal of Molecular Imaging, (20140331), vol. 2014, doi:10.1155/2014/269365, ISSN 2090-1712, pages 1 - 7, XP055843708
OPPOSITION- Schäfer Martin, Bauder-Wüst Ulrike, Leotta Karin, Zoller Frederic, Mier Walter, Haberkorn Uwe, Eisenhut Michael, Eder Matthias, "A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68 Ga-PET imaging of prostate cancer", EJNMMI Research, Springer, (20120606), vol. 2, no. 1, doi:10.1186/2191-219X-2-23, ISSN 2191-219X, pages 23 - 11, XP093201855
OPPOSITION- Decristoforo Clemens, "Gallium-68 - A New Opportunity For PET Available From a Long Shelflife Generator - Automation and Applications", CURRENT RADIOPHARMACEUTICALS, Bentham Science Publishers Ltd., NL, NL , (20120601), vol. 5, no. 3, doi:10.2174/1874471011205030212, ISSN 1874-4710, pages 212 - 220, XP093201865
OPPOSITION- K.P.ZHERNOSEKOV,D.V.FILOSOFOV,R.P.BAUM,P.ASCHOFF,H.BIHL,A.A.RAZBASH,M.JAHN,M.JENNEWEIN,F.RÖSCH, "Processing of Generator-Produced 68Ga for Medical Application", The Journal of Nuclear Medicine, Society of Nuclear Medicine, US, US , (20070101), vol. 48, no. 10, doi:10.2967/jnumed.107.040378, ISSN 0161-5505, pages 1741 - 1748, XP002542829
OPPOSITION- C. Wangler, B. Wangler, S. Lehner, A. Elsner, A. Todica, P. Bartenstein, M. Hacker, R. Schirrmacher, "A Universally Applicable 68Ga-Labeling Technique for Proteins", The Journal of Nuclear Medicine, Society of Nuclear Medicine, US, US , (20110401), vol. 52, no. 4, doi:10.2967/jnumed.110.082198, ISSN 0161-5505, pages 586 - 591, XP055544743
OPPOSITION- Eiber Matthias, Maurer Tobias, Souvatzoglou Michael, Beer Ambros J., Ruffani Alexander, Haller Bernhard, Graner Frank-Philipp, Kübler Hubert, Haberhorn Uwe, Eisenhut Michael, Wester Hans-Jürgen, Gschwend Jürgen E., Schwaiger Markus, "Evaluation of Hybrid 68 Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy", The Journal of Nuclear Medicine, Society of Nuclear Medicine, US, US , (20150501), vol. 56, no. 5, doi:10.2967/jnumed.115.154153, ISSN 0161-5505, pages 668 - 674, XP055839872
OPPOSITION- Thomas Ebenhan, Mariza Vorster, Biljana Marjanovic-Painter, Judith Wagener, Janine Suthiram, Moshe Modiselle, Brenda Mokaleng, Jan Zeevaart, Mike Sathekge, "Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients", Molecules, (20150101), vol. 20, no. 8, doi:10.3390/molecules200814860, pages 14860 - 14878, XP055289112
OPPOSITION- Matthias Eder, Oliver Neels, Miriam Müller, Ulrike Bauder-Wüst, Yvonne Remde, Martin Schäfer, Ute Hennrich, Michael Eisenhut, Ali Afshar-Oromieh, Uwe Haberkorn, Klaus Kopka, "Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer", Pharmaceuticals, (20140701), vol. 7, no. 7, doi:10.3390/ph7070779, pages 779 - 796, XP055280737
OPPOSITION- Irina Velikyan, "Prospective of 68 Ga-Radiopharmaceutical Development", THERANOSTICS, Ivyspring International Publisher, AU, AU , (20140101), vol. 4, no. 1, doi:10.7150/thno.7447, ISSN 1838-7640, pages 47 - 80, XP055544735
SEARCH- KRATOCHWIL CLEMENS ET AL, "[177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER VERLAG, HEIDELBERG, DE, vol. 42, no. 6, doi:10.1007/S00259-014-2978-1, ISSN 1619-7070, (20150109), pages 987 - 988, (20150109), XP035444727 [A] 1-11 * the whole document *
SEARCH- ARCHANA MUKHERJEE ET AL, "Development of Single Vial Kits for Preparation of 68Ga-Labelled Peptides for PET Imaging of Neuroendocrine Tumours", MOLECULAR IMAGING & BIOLOGY, Boston, (20140130), vol. 16, no. 4, doi:10.1007/s11307-014-0719-2, ISSN 1536-1632, pages 550 - 557, XP055289358 [A] 1-11 * page 552, sections "Kit Formulation of DOTA-TOC, DOTA-NOC and DOTA-TATE Peptides", "68Ga Labelling of DOTA-Peptide Kits" * * page 556, column 2, lines 1-5 * * page 556, section "Conclusion" *
SEARCH[ ] - SATPATI DRISHTY ET AL, "Convenient Preparation of [68Ga]DKFZ-PSMA-11 Using a Robust Single-Vial Kit and Demonstration of Its Clinical Efficacy", MOLECULAR IMAGING & BIOLOGY, ELSEVIER, BOSTON, vol. 18, no. 3, doi:10.1007/S11307-016-0943-Z, ISSN 1536-1632, (20160316), pages 420 - 427, (20160316), XP035936489 [ ] * abstract * * page 422, section "Preparation of DKFZ-PSMA-11 Kits" * * page 422, section "Ga-68 Labeling of Kit Vials" *
SEARCH- MATTHIAS EDER ET AL, "68 Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging", BIOCONJUGATE CHEMISTRY, (20120418), vol. 23, no. 4, doi:10.1021/bc200279b, ISSN 1043-1802, pages 688 - 697, XP055043532 [A] 1-11 * abstract * * scheme 1 * * scheme 2 * * pages 691-692, section "Radiolabeling and Stability" *
SEARCH- THOMAS EBENHAN ET AL, "Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients", MOLECULES, (20150814), vol. 20, no. 8, doi:10.3390/molecules200814860, pages 14860 - 14878, XP055289112 [PX] 1-9 * abstract * * page 14872, section "3.4 In-House Kit Vial Formulation of DKFZ-PSMA-11" * * page 14872, section "3.5 68Ga Radiolabeling of DKFZ-PSMA-11 Kits" *
SEARCH- MATTHIAS EDER ET AL, "Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer", PHARMACEUTICALS, (20140630), vol. 7, no. 7, doi:10.3390/ph7070779, pages 779 - 796, XP055280737 [A] 1-11 * abstract * * page 782, section "2.2.1. 68Ga-Radiolabelling" *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents